- Home
- SOND vs ICU Comparison
SOND vs ICU Comparison
Compare SOND & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOND
- ICU
- Stock Information
- Founded
- SOND 2014
- ICU 2018
- Country
- SOND United States
- ICU United States
- Employees
- SOND N/A
- ICU N/A
- Industry
- SOND Hotels/Resorts
- ICU Biotechnology: Pharmaceutical Preparations
- Sector
- SOND Consumer Discretionary
- ICU Health Care
- Exchange
- SOND Nasdaq
- ICU Nasdaq
- Market Cap
- SOND 17.2M
- ICU 15.9M
- IPO Year
- SOND N/A
- ICU N/A
- Fundamental
- Price
- SOND $0.94
- ICU $0.63
- Analyst Decision
- SOND
- ICU
- Analyst Count
- SOND 0
- ICU 0
- Target Price
- SOND N/A
- ICU N/A
- AVG Volume (30 Days)
- SOND 3.0M
- ICU 2.3M
- Earning Date
- SOND 10-14-2025
- ICU 11-12-2025
- Dividend Yield
- SOND N/A
- ICU N/A
- EPS Growth
- SOND N/A
- ICU N/A
- EPS
- SOND N/A
- ICU N/A
- Revenue
- SOND $589,133,000.00
- ICU $766,000.00
- Revenue This Year
- SOND $46.47
- ICU $820.00
- Revenue Next Year
- SOND N/A
- ICU $63.37
- P/E Ratio
- SOND N/A
- ICU N/A
- Revenue Growth
- SOND N/A
- ICU N/A
- 52 Week Low
- SOND $0.91
- ICU $0.31
- 52 Week High
- SOND $4.99
- ICU $4.22
- Technical
- Relative Strength Index (RSI)
- SOND 38.36
- ICU 45.10
- Support Level
- SOND $0.95
- ICU $0.60
- Resistance Level
- SOND $1.76
- ICU $0.65
- Average True Range (ATR)
- SOND 0.18
- ICU 0.06
- MACD
- SOND 0.00
- ICU 0.01
- Stochastic Oscillator
- SOND 3.93
- ICU 52.58
About SOND Sonder Holdings Inc.
Sonder Holdings Inc is engaged in providing short and long-term accommodations to travelers in various cities across North America, Europe, and the Middle East. The Sonder units in each apartment-style building and each hotel property are selected, designed, and managed directly by the Company. The Company generates revenues by providing short-term or month-to-month accommodations to its guests. The Company also provides accommodations to travelers through boutique hotels.
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.